View in browser

Join us for our first annual Office of Translational Science Retreat, "Sparkathon"! This event aims to “spark” collaborative translational efforts and foster networking among researchers across diverse disciplines and programs. Our keynote speaker, Dr. Himisha Beltran from the Dana-Farber Cancer Institute, a distinguished medical oncologist, and physician-scientist, will share insights into treatment resistance mechanisms in prostate cancer and lineage plasticity during cancer evolution. The keynote and associated panel discussion will provide valuable insights on vital translational processes, featuring an interactive Q&A. The retreat includes a community-scientist program, rapid-fire translational science talks, structured networking sessions, and an exciting opportunity to competitively pitch your translational concept for potential seed funding. Don't miss this chance to be part of a dynamic and collaborative scientific experience!

The Sanford Stem Cell Institute sent the first patient-derived metastatic breast cancer organoids into space as part of the Axiom 3 spaceflight, which launched from Kennedy Space Center January 17. This new round of research aims to repeat prior experiments with Fedratinib and Rebecsinib as well as gain new insight into cancer’s ability to clone itself and metastasize under stressful conditions.

National Mentoring Month is January 1–30. Mentorship is a key part of building a more diverse cancer research workforce. Drs. Aristizabal and Martinez were interviewed as part of the NCI Center to Reduce Cancer Health Disparities (CRCHD)’s series of mentorship Q&As, focused on providing new perspectives and insightful guidance from mentors and mentees alike.

UC San Diego’s excellence in research, innovation, and discovery, has a new tool, the new Chancellor’s Interdisciplinary Team Catalyst Awards. The awards aim to foster sustainable, interdisciplinary collaborations and to assist teams in developing tailored funding strategies for grand scientific and societal challenges. The Team Catalyst Awards will function as an internal funding source to support the creation and sustainability of team-based research projects over a 2-to-5-year horizon.

January 29, 2024 | 12:00 p.m.

Comer Commons

January 30, 2024 | 12:00 p.m.

Leichtag Biomedical Research Building Room 107 

February 5, 2024 | 12:00 p.m.

Comer Commons

February 5, 2024 | 3:00 to 4:00 p.m.

Sanford Consortium for Regenerative Medicine Room 1013 A/B

Join Drs. Pamela Maher, Claude Sirlin and Carrie House to gain expert advice from UC San Diego, San Diego State University, and Salk Institute for Biological Studies faculty members. All students, postdocs, and junior faculty are welcome to attend!

Dr. Jing Yang and Dr. Dan Donoghue are opening the call for nominations for the NCI T32 Training Grant in Cancer Cell Signaling & Communication Program. They are looking for outstanding postdoctoral trainees working on cancer research projects from your lab. All trainees accepted into their program are expected to have strong and diverse backgrounds in cancer biology, biochemistry, molecular and cell biology, chemistry, or bioengineering. Nominations for the training program must be submitted by February 19, 2024.

As a member of the next generation of translational surgeon-scientists, you will undergo rigorous training in three disciplines: 1) the tumor microenvironment; 2) techniques of biobanking; and 3) innovation and entrepreneurship. This is a truly unique, one of a kind training program, and is located at an elite institution with a Training Faculty composed of 18 NIH-funded ($28.1 million per year; $18.5 million in direct costs) Faculty Mentors. Applications must be submitted by March 1, 2024.

The CT2 Program is open to both MDs and PhDs and provides an intensive 2-year period of research and training in the development of novel cancer therapeutics or diagnostics at the Moores Cancer Center. Trainees not only execute a research program under the direction of a member of the faculty of this Comprehensive Cancer Center, but also participate in coursework, seminars, and lectures. Graduates of the program are prepared to transition to leadership roles in cancer therapeutics development in either an academic or commercial environment.

Applications must be submitted by March 15, 2024.

The Pediatric Cancer Research Foundation (PCRF) has three Limited Submission grant opportunities: Basic Science Research Grants (up to $150,000 per year, for up to 3 years), Translational Research Grants (up to $75,000 per year, for up to 2 years), and Emerging Investigator Fellowship Grants (up to $60,000 for one year). You can learn more about each of these three research grants here. LOIs are due to PCRF March 1, full proposals (based on approved LOI by PCRF) by June 1. If you are interested in being the MCC nominee for one of the above grants, please submit a 1-page Research Statement via InfoReady for review by our grants committee.

Internal Submission Deadline: February 2, 2024

The foundation invites applicants whose primary focus is breast cancer to apply for either the Exceptional Project or Young Investigator research grants. Exceptional Project Grants recognize creative, unique and innovative research and are open to applicants at institutions in the contiguous United States. This one-year grant provides salary support and project costs for a total of $100,000. Young Investigator Grants are intended to encourage a commitment to breast cancer research for applicants who are in the early stages of their careers. This is a two-year grant for a total of $125,000.

Internal Submission Deadline: February 8, 2024 at 5:00 p.m.

This seed grant funding opportunity supports preliminary findings and exploratory new concepts in early to late- stage gene therapy-related programs. Our aim is to help bridge critical gaps between good ideas and breakthrough discoveries by fostering collaborative interactions to expedite the translation of research into therapeutic treatments. Up to $100K will be awarded per project over a one-year term. 

Deadline: Friday, March 1, 2024

Questions? Contact GTI_admin@health.ucsd.edu

Lancet Oncology

Jyoti Mayadev, MD

Solid Tumor Therapeutics

Nature Immunology

Enfu Hui, PhD

Hematologic Malignancies

Molecular Cell

Michael G. Rosenfeld, MD

Structural and Functional Genomics

No newly opened clinical trials.

This mixer is for researchers to connect with community members and community organizations, leading to discussions and networking around cancer prevention, early detection, treatment, survivorship support, and services throughout San Diego and Imperial Counties, with an emphasis on underserved and uninsured communities.

Engaging the community and catchment area priorities are extremely important for our cancer center!

Light refreshments will be provided to attendees.

Register Now

We are hiring! The Community Outreach & Engagement team is looking for two passionate Health Educators to join them! As a Health Educator, you'll play a crucial role in fostering community wellness, raising awareness about cancer prevention and delivering educational resources. Please share with your network! 

Community Health Liaison Practice Focus (1/30 deadline)

Community Health Liaison CREATE (1/31 deadline)

Moores Cancer Center alongside Cloudcast Media and the Jackie Robinson Y kicked off their first podcast recording session of the year featuring Dr. Jessica Carrasco and Dexter Pratt! Dr. Carrasco discussed the impact of emotions, while Dexter covered all things AI and the future. Interested in being a guest? We record the last Thursday of every month from 4-6 in Comer Commons. Contact mcccoe@health.ucsd.edu to learn more about becoming a guest on The Science Of!

Listen Now

Director of the National Institutes of Health Monica Bertagnolli, M.D. will give a talk during the meeting. The NACMHD advises the Secretary of Health and Human Services, the NIH Director, and the NIMHD Director on matters related to the Institute’s mission. 

Watch the Videocast

Applications for the 2024 Health Disparities Research Institute (HDRI) will be accepted from February 5 – March 11, 2024. HDRI will take place on August 6 – 9, 2024 and is a unique weeklong program that supports the research career development of promising early-career minority health and health disparities research scientists.

Learn More

PRE is a 2-day, in-person event held on May 1-2, 2024, at the National Institutes of Health (NIH). PRE provides Ph.D. candidates the opportunity to explore postdoctoral opportunities and determine if the National Cancer Institute (NCI) is an ideal fit for their professional goals. 

A pre-application webinar for the PRE program will be held on Tuesday, January 23, 2024 from 2:30 - 3:30 p.m. ET. Register Now. Application deadline is Wednesday, February 7, 2024.

Apply Now

Make progress on writing projects in a supportive community with other faculty! This 2-day retreat is organized by the Center for Faculty Diversity and Inclusion and facilitated by Chrissy Sharp, Director of Writing and Communication Learning Services at the Commons. Enrollment in the retreat includes facilitation, meals, optional writing consults, and support for dependent care. Applications are due on February 20, 2024.

Apply Now

Department of Research Administration

3855 Health Sciences Drive, La Jolla, CA 92037

moorescancercenter.ucsd.edu

Unsubscribe | Privacy Policy | Submit Feedback